Global Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 29-Jan-2020
No. of pages: 99
Inquire Before Buying

This report focuses on the global Beta-lactam and Beta-lactamase Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Beta-lactam and Beta-lactamase Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- Abbott Laboratories

- Allergan Plc.

- F. Hoffmann-La Roche Ltd.

- GlaxoSmithKline plc

- Merck & Co. Inc.

- Mylan N.V.

- Novartis International AG (Sandoz)

- Pfizer Inc.

- Sanofi

- Teva Pharmaceutical Industries Ltd

Market segment by Type, the product can be split into

- Penicillin

- Cephalosporin

- Carbapenem

- Monobactam

- Combination

Market segment by Application, split into

- Oral

- Intravenous

- Others

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Beta-lactam and Beta-lactamase Inhibitors status, future forecast, growth opportunity, key market and key players.

- To present the Beta-lactam and Beta-lactamase Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Beta-lactam and Beta-lactamase Inhibitors are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Beta-lactam and Beta-lactamase Inhibitors Revenue
1.4 Market Analysis by Type
1.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Penicillin
1.4.3 Cephalosporin
1.4.4 Carbapenem
1.4.5 Monobactam
1.4.6 Combination
1.5 Market by Application
1.5.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Application: 2020 VS 2026
1.5.2 Oral
1.5.3 Intravenous
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Beta-lactam and Beta-lactamase Inhibitors Market Perspective (2015-2026)
2.2 Beta-lactam and Beta-lactamase Inhibitors Growth Trends by Regions
2.2.1 Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Beta-lactam and Beta-lactamase Inhibitors Historic Market Share by Regions (2015-2020)
2.2.3 Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Beta-lactam and Beta-lactamase Inhibitors Market Growth Strategy
2.3.6 Primary Interviews with Key Beta-lactam and Beta-lactamase Inhibitors Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Market Size
3.1.1 Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Revenue (2015-2020)
3.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Players (2015-2020)
3.1.3 Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Concentration Ratio
3.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Beta-lactam and Beta-lactamase Inhibitors Revenue in 2019
3.3 Beta-lactam and Beta-lactamase Inhibitors Key Players Head office and Area Served
3.4 Key Players Beta-lactam and Beta-lactamase Inhibitors Product Solution and Service
3.5 Date of Enter into Beta-lactam and Beta-lactamase Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Beta-lactam and Beta-lactamase Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Type (2021-2026)
5 Beta-lactam and Beta-lactamase Inhibitors Breakdown Data by Application (2015-2026)
5.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020)
5.2 Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size (2015-2020)
6.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in North America (2019-2020)
6.3 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020)
6.4 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020)
7 Europe
7.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size (2015-2020)
7.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in Europe (2019-2020)
7.3 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020)
7.4 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020)
8 China
8.1 China Beta-lactam and Beta-lactamase Inhibitors Market Size (2015-2020)
8.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in China (2019-2020)
8.3 China Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020)
8.4 China Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020)
9 Japan
9.1 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size (2015-2020)
9.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in Japan (2019-2020)
9.3 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020)
9.4 Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size (2015-2020)
10.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020)
11 India
11.1 India Beta-lactam and Beta-lactamase Inhibitors Market Size (2015-2020)
11.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in India (2019-2020)
11.3 India Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020)
11.4 India Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size (2015-2020)
12.2 Beta-lactam and Beta-lactamase Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Introduction
13.1.4 Abbott Laboratories Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Allergan Plc.
13.2.1 Allergan Plc. Company Details
13.2.2 Allergan Plc. Business Overview and Its Total Revenue
13.2.3 Allergan Plc. Beta-lactam and Beta-lactamase Inhibitors Introduction
13.2.4 Allergan Plc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
13.2.5 Allergan Plc. Recent Development
13.3 F. Hoffmann-La Roche Ltd.
13.3.1 F. Hoffmann-La Roche Ltd. Company Details
13.3.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
13.3.3 F. Hoffmann-La Roche Ltd. Beta-lactam and Beta-lactamase Inhibitors Introduction
13.3.4 F. Hoffmann-La Roche Ltd. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Ltd. Recent Development
13.4 GlaxoSmithKline plc
13.4.1 GlaxoSmithKline plc Company Details
13.4.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
13.4.3 GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Introduction
13.4.4 GlaxoSmithKline plc Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
13.4.5 GlaxoSmithKline plc Recent Development
13.5 Merck & Co. Inc.
13.5.1 Merck & Co. Inc. Company Details
13.5.2 Merck & Co. Inc. Business Overview and Its Total Revenue
13.5.3 Merck & Co. Inc. Beta-lactam and Beta-lactamase Inhibitors Introduction
13.5.4 Merck & Co. Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
13.5.5 Merck & Co. Inc. Recent Development
13.6 Mylan N.V.
13.6.1 Mylan N.V. Company Details
13.6.2 Mylan N.V. Business Overview and Its Total Revenue
13.6.3 Mylan N.V. Beta-lactam and Beta-lactamase Inhibitors Introduction
13.6.4 Mylan N.V. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
13.6.5 Mylan N.V. Recent Development
13.7 Novartis International AG (Sandoz)
13.7.1 Novartis International AG (Sandoz) Company Details
13.7.2 Novartis International AG (Sandoz) Business Overview and Its Total Revenue
13.7.3 Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Introduction
13.7.4 Novartis International AG (Sandoz) Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
13.7.5 Novartis International AG (Sandoz) Recent Development
13.8 Pfizer Inc.
13.8.1 Pfizer Inc. Company Details
13.8.2 Pfizer Inc. Business Overview and Its Total Revenue
13.8.3 Pfizer Inc. Beta-lactam and Beta-lactamase Inhibitors Introduction
13.8.4 Pfizer Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
13.8.5 Pfizer Inc. Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview and Its Total Revenue
13.9.3 Sanofi Beta-lactam and Beta-lactamase Inhibitors Introduction
13.9.4 Sanofi Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
13.9.5 Sanofi Recent Development
13.10 Teva Pharmaceutical Industries Ltd
13.10.1 Teva Pharmaceutical Industries Ltd Company Details
13.10.2 Teva Pharmaceutical Industries Ltd Business Overview and Its Total Revenue
13.10.3 Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Introduction
13.10.4 Teva Pharmaceutical Industries Ltd Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
13.10.5 Teva Pharmaceutical Industries Ltd Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Beta-lactam and Beta-lactamase Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by Beta-lactam and Beta-lactamase Inhibitors Revenue
Table 3. Ranking of Global Top Beta-lactam and Beta-lactamase Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Penicillin
Table 6. Key Players of Cephalosporin
Table 7. Key Players of Carbapenem
Table 8. Key Players of Monobactam
Table 9. Key Players of Combination
Table 10. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2015-2020)
Table 14. Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Beta-lactam and Beta-lactamase Inhibitors Market Growth Strategy
Table 20. Main Points Interviewed from Key Beta-lactam and Beta-lactamase Inhibitors Players
Table 21. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 22. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Players (2015-2020)
Table 23. Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beta-lactam and Beta-lactamase Inhibitors as of 2019)
Table 24. Global Beta-lactam and Beta-lactamase Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Beta-lactam and Beta-lactamase Inhibitors Product Solution and Service
Table 27. Date of Enter into Beta-lactam and Beta-lactamase Inhibitors Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 30. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Share by Type (2015-2020)
Table 31. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2021-2026)
Table 32. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Share by Application (2015-2020)
Table 33. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 34. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Share by Application (2021-2026)
Table 35. North America Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2019-2020)
Table 37. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 38. North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2015-2020)
Table 39. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 40. North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2015-2020)
Table 41. Europe Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2019-2020)
Table 43. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2015-2020)
Table 45. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2015-2020)
Table 47. China Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2019-2020) (Million US$)
Table 48. China Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2019-2020)
Table 49. China Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 50. China Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2015-2020)
Table 51. China Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 52. China Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2015-2020)
Table 53. Japan Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2019-2020)
Table 55. Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2015-2020)
Table 57. Japan Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2019-2020)
Table 61. Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2015-2020)
Table 63. Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2015-2020)
Table 65. India Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2019-2020) (Million US$)
Table 66. India Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2019-2020)
Table 67. India Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 68. India Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2015-2020)
Table 69. India Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 70. India Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Beta-lactam and Beta-lactamase Inhibitors Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Beta-lactam and Beta-lactamase Inhibitors Market Share (2019-2020)
Table 73. Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2015-2020)
Table 75. Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. Allergan Plc. Company Details
Table 83. Allergan Plc. Business Overview
Table 84. Allergan Plc. Product
Table 85. Allergan Plc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 86. Allergan Plc. Recent Development
Table 87. F. Hoffmann-La Roche Ltd. Company Details
Table 88. F. Hoffmann-La Roche Ltd. Business Overview
Table 89. F. Hoffmann-La Roche Ltd. Product
Table 90. F. Hoffmann-La Roche Ltd. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 91. F. Hoffmann-La Roche Ltd. Recent Development
Table 92. GlaxoSmithKline plc Company Details
Table 93. GlaxoSmithKline plc Business Overview
Table 94. GlaxoSmithKline plc Product
Table 95. GlaxoSmithKline plc Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 96. GlaxoSmithKline plc Recent Development
Table 97. Merck & Co. Inc. Company Details
Table 98. Merck & Co. Inc. Business Overview
Table 99. Merck & Co. Inc. Product
Table 100. Merck & Co. Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 101. Merck & Co. Inc. Recent Development
Table 102. Mylan N.V. Company Details
Table 103. Mylan N.V. Business Overview
Table 104. Mylan N.V. Product
Table 105. Mylan N.V. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 106. Mylan N.V. Recent Development
Table 107. Novartis International AG (Sandoz) Company Details
Table 108. Novartis International AG (Sandoz) Business Overview
Table 109. Novartis International AG (Sandoz) Product
Table 110. Novartis International AG (Sandoz) Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 111. Novartis International AG (Sandoz) Recent Development
Table 112. Pfizer Inc. Business Overview
Table 113. Pfizer Inc. Product
Table 114. Pfizer Inc. Company Details
Table 115. Pfizer Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 116. Pfizer Inc. Recent Development
Table 117. Sanofi Company Details
Table 118. Sanofi Business Overview
Table 119. Sanofi Product
Table 120. Sanofi Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 121. Sanofi Recent Development
Table 122. Teva Pharmaceutical Industries Ltd Company Details
Table 123. Teva Pharmaceutical Industries Ltd Business Overview
Table 124. Teva Pharmaceutical Industries Ltd Product
Table 125. Teva Pharmaceutical Industries Ltd Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020) (Million US$)
Table 126. Teva Pharmaceutical Industries Ltd Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. Penicillin Features
Figure 3. Cephalosporin Features
Figure 4. Carbapenem Features
Figure 5. Monobactam Features
Figure 6. Combination Features
Figure 7. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Application: 2020 VS 2026
Figure 8. Oral Case Studies
Figure 9. Intravenous Case Studies
Figure 10. Others Case Studies
Figure 11. Beta-lactam and Beta-lactamase Inhibitors Report Years Considered
Figure 12. Global Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions: 2020 VS 2026
Figure 14. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Players in 2019
Figure 17. Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beta-lactam and Beta-lactamase Inhibitors as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Beta-lactam and Beta-lactamase Inhibitors Revenue in 2019
Figure 19. North America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Laboratories Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 28. Allergan Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Allergan Plc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 30. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 32. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline plc Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 34. Merck & Co. Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Merck & Co. Inc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 36. Mylan N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Mylan N.V. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 38. Novartis International AG (Sandoz) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Novartis International AG (Sandoz) Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 40. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Pfizer Inc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 42. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Sanofi Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 44. Teva Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
  • 2021-2027 Global and Regional Bathroom & Toilet Assist Devices Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Sep-2021        Price: US 3500 Onwards        Pages: 144
    The global Bathroom & Toilet Assist Devices market was valued at 3550.68 Million USD in 2020 and will grow with a CAGR of 3.33% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, ......
  • 2021-2027 Global and Regional Cardiopulmonary Auto-transfusion System Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Sep-2021        Price: US 3500 Onwards        Pages: 141
    The global Cardiopulmonary Auto-transfusion System market was valued at 549.81 Million USD in 2020 and will grow with a CAGR of 1.83% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North Ame......
  • 2021-2027 Global and Regional Pharmaceutical Grade Phycocyanin Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global Pharmaceutical Grade Phycocyanin market was valued at 31.33 Million USD in 2020 and will grow with a CAGR of 5.36% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, Ea......
  • 2021-2027 Global and Regional Extracorporeal CO2 Removal Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Sep-2021        Price: US 3500 Onwards        Pages: 145
    The global Extracorporeal CO2 Removal market was valued at 21.95 Million USD in 2020 and will grow with a CAGR of 3.34% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asi......
  • 2021-2027 Global and Regional Smart Pulse Oximeters Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Sep-2021        Price: US 3500 Onwards        Pages: 157
    The global Smart Pulse Oximeters market was valued at 757.06 Million USD in 2020 and will grow with a CAGR of 4.98% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, E......
  • 2021-2027 Global and Regional Creatinine Assay Kits Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Sep-2021        Price: US 3500 Onwards        Pages: 167
    The global Creatinine Assay Kits market was valued at 170.01 Million USD in 2020 and will grow with a CAGR of 2.96% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, E......
  • 2021-2027 Global and Regional Surgical Equipment/Instruments Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Sep-2021        Price: US 3500 Onwards        Pages: 152
    The global Surgical Equipment/Instruments market was valued at 1056.77 Million USD in 2020 and will grow with a CAGR of 4.69% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, Ea......
  • 2021-2027 Global and Regional Chronic Kidney Disease (CKD) Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Sep-2021        Price: US 3500 Onwards        Pages: 159
    The global Chronic Kidney Disease (CKD) market was valued at 125.86 Million USD in 2020 and will grow with a CAGR of 4.01% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East ......
  • 2021-2027 Global and Regional Chenodeoxycholic Acid Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 27-Sep-2021        Price: US 3500 Onwards        Pages: 168
    The global Chenodeoxycholic Acid market was valued at 345.07 Million USD in 2020 and will grow with a CAGR of 6.24% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, E......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs